On the other hand, PARP1 inhibition and deletion in mice were associated with improvement of diabetes- or obesity-related parameters such as glucose tolerance, weight loss, or fat mass reduction (reviewed in Bai and Cantó, 2012; Table 1). This evidence concerns the gene PARP1 and obesity due to melanocortin 4 receptor deficiency.